Atlas Trials

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Clinical trial NCT00734773 · WITHDRAWN

Trial details

NCT number
NCT00734773
Sponsor
Northwestern University
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Brain and Central Nervous System TumorsLymphomaNeurotoxicity
Start date
2008-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.